| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 96/09/05 | 104/11/23 | 張念原 | 張金明 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.19(Q2) | 0 | 8.36 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 2,529,349,800 | 252,934,980 | ||
| 主要經營業務 | |||
| 新藥研發 | |||
| 公司網址 | |||
| tmb.com.tw | |||
中裕(4147) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 49,537 | 29,926 | 7.7% | 65.5% | 271,532 | 197,975 | 37.2% |
| 2023/07 | 45,985 | 28,093 | 41.9% | 63.7% | 221,995 | 168,049 | 32.1% |
| 2023/06 | 32,408 | 27,400 | 7.2% | 18.3% | 176,010 | 139,956 | 25.8% |
| 2023/05 | 30,241 | 31,306 | -27.3% | -3.4% | 143,602 | 112,555 | 27.6% |
| 2023/04 | 41,593 | 40,578 | 83.5% | 2.5% | 113,360 | 81,249 | 39.5% |
| 2023/03 | 22,666 | 12,886 | -6.2% | 75.9% | 71,767 | 40,671 | 76.4% |
| 2023/02 | 24,153 | 14,359 | -3.2% | 68.2% | 49,101 | 27,784 | 76.7% |
| 2023/01 | 24,948 | 13,425 | -74.2% | 85.8% | 24,948 | 13,425 | 85.8% |
| 2022/12 | 96,794 | 18,630 | -26.8% | 419.5% | 565,929 | 413,442 | 36.9% |
| 2022/11 | 132,192 | 21,101 | 31.6% | 526.5% | 469,134 | 394,812 | 18.8% |
| 2022/10 | 100,407 | 36,128 | 160.4% | 177.9% | 336,942 | 373,711 | -9.8% |
| 2022/09 | 38,560 | 28,032 | 28.9% | 37.5% | 236,535 | 337,583 | -29.9% |
| 2022/08 | 29,926 | 30,865 | 6.5% | -3% | 197,975 | 309,552 | -36% |
| 2022/07 | 28,093 | 32,228 | 2.5% | -12.8% | 168,049 | 278,687 | -39.7% |
| 2022/06 | 27,400 | 46,496 | -12.5% | -41.1% | 139,956 | 246,458 | -43.2% |
| 2022/05 | 31,306 | 51,791 | -22.8% | -39.5% | 112,555 | 199,963 | -43.7% |
| 2022/04 | 40,578 | 56,912 | 214.9% | -28.7% | 81,249 | 148,172 | -45.2% |
| 2022/03 | 12,886 | 8,782 | -10.3% | 46.7% | 40,671 | 91,260 | -55.4% |
| 2022/02 | 14,359 | 41,164 | 6.9% | -65.1% | 27,784 | 82,478 | -66.3% |
| 2022/01 | 13,425 | 41,314 | -27.9% | -67.5% | 13,425 | 41,314 | -67.5% |
| 2021/12 | 18,630 | 40,351 | -11.7% | -53.8% | 413,442 | 722,485 | -42.8% |
| 2021/11 | 21,101 | 55,986 | -41.6% | -62.3% | 394,812 | 682,135 | -42.1% |
| 2021/10 | 36,128 | 57,083 | 28.9% | -36.7% | 373,711 | 626,148 | -40.3% |
| 2021/09 | 28,032 | 403 | -9.2% | 6855.8% | 337,583 | 569,066 | -40.7% |
| 2021/08 | 30,865 | 54,585 | -4.2% | -43.5% | 309,552 | 568,663 | -45.6% |
| 2021/07 | 32,228 | 95,830 | -30.7% | -66.4% | 278,687 | 514,078 | -45.8% |
| 2021/06 | 46,496 | 46,069 | -10.2% | 0.9% | 246,458 | 418,248 | -41.1% |
| 2021/05 | 51,791 | 63,864 | -9% | -18.9% | 199,963 | 372,179 | -46.3% |
| 2021/04 | 56,912 | 69,121 | 548% | -17.7% | 148,172 | 308,315 | -51.9% |
| 2021/03 | 8,782 | 119,016 | -78.7% | -92.6% | 91,260 | 239,194 | -61.8% |
| 2021/02 | 41,164 | 29,759 | -0.4% | 38.3% | 82,478 | 120,179 | -31.4% |
| 2021/01 | 41,314 | 90,420 | 2.4% | -54.3% | 41,314 | 90,420 | -54.3% |
| 2020/12 | 40,351 | 0 | -27.9% | 0% | 722,485 | 704,121 | 2.6% |
| 2020/11 | 55,986 | 98,852 | -1.9% | -43.4% | 682,135 | 704,121 | -3.1% |
| 2020/10 | 57,083 | 109,671 | 14064.5% | -48% | 626,148 | 605,269 | 3.4% |
| 2020/09 | 403 | 70,067 | -99.3% | -99.4% | 569,066 | 495,598 | 14.8% |
評論0